<i>DSM-5</i> Mixed Specifier for Manic Episodes: Asenapine Efficacy in Pediatric Patients With a Manic or Mixed Episode Associated with Bipolar I Disorder

New Research Poster Presentation 5.39
DSM-5 Mixed Specifier for Manic Episodes: Asenapine Efficacy in Pediatric Patients With a Manic or Mixed Episode Associated with Bipolar I Disorder

Friday, October 30, 2015 12:30 PM

Roger S. McIntyre, MD, FRCPC, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada

Ronald Landbloom, MD, Merck & Co., Inc., Whitehouse Station, NJ

Carla Hundt, MD, Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ

Xiao Wu, PhD, Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ

Robert L. Findling, MD, MBA, Department of Psychiatry, The Johns Hopkins University and Kennedy Krieger Institute, Baltimore, MD